Physician

Aleksander Vayntraub, MD

According to 2025 Medicare claims, Aleksander Vayntraub, MD (NPI: 1316467582) practices radiation oncology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (NPI: 1396794574; TIN: 112419534) and primary practice location at 11772-4808. Vayntraub is affiliated with the ilumed, LLC (ACO ID: D0005), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Vayntraub's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 706 traditional Medicare patients, billed 8,459 HCPCS/CPT codes, and received $2,380,126 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 309 prescription claims across 126 beneficiaries totaling $3,768 in drug costs, led by Mometasone Furoate (Mometasone Furoate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $990 to $3,768. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2022 Medicare payment: $725,755 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,133,302 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,380,126 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222182,525$725,755
20236477,464$2,133,302
20247068,459$2,380,126

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.4K$8.8K2018 Drug cost: $990 (USD; Tot_Drug_Cst)2019 Drug cost: $97 (USD; Tot_Drug_Cst)2020 Drug cost: $245 (USD; Tot_Drug_Cst)2021 Drug cost: $380 (USD; Tot_Drug_Cst)2022 Drug cost: $1,595 (USD; Tot_Drug_Cst)2023 Drug cost: $8,774 (USD; Tot_Drug_Cst)2024 Drug cost: $3,768 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182540$990
2019N/R13$97
2020N/R11$245
20211218$380
20224159$1,595
2023138312$8,774
2024126309$3,768

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session2492,017$331
77263Complex radiation therapy planning199212$149
77334Design and construction of complex radiation treatment device192273$113
77014Ct guidance for insertion of radiation therapy fields2371,970$108
77336Continuing radiation therapy consultation per week246548$84

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Mometasone FuroateMometasone Furoate27867$447
Lidocaine Hcl ViscousLidocaine Hcl23326$329
Tamsulosin HclTamsulosin Hcl292,000$326
DexamethasoneDexamethasone18305$265
Silver SulfadiazineSilver Sulfadiazine15452$250

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Aleksander Vayntraub, MD?

Tedicare shows public-source Medicare data for Aleksander Vayntraub, MD (NPI 1316467582), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aleksander Vayntraub, MD have ACO affiliation data?

Aleksander Vayntraub, MD is shown with ACO affiliation data for ilumed, LLC (REACH, ACO ID D0005), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Aleksander Vayntraub, MD?

Aleksander Vayntraub, MD is linked to NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (billing NPI 1396794574) in the available physician profile data.

Does Aleksander Vayntraub, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.